Radiation Protection and Mitigation by Natural Antioxidants and Flavonoids: Implications to Radiotherapy and Radiation Disasters
- PMID: 29921213
- DOI: 10.2174/1874467211666180619125653
Radiation Protection and Mitigation by Natural Antioxidants and Flavonoids: Implications to Radiotherapy and Radiation Disasters
Abstract
Background: Nowadays, ionizing radiations are used for various medical and terroristic aims. These purposes involve exposure to ionizing radiations. Hence, people are at risk for acute or late effects. Annually, millions of cancer patients undergo radiotherapy during their course of treatment. Also, some radiological or nuclear events in recent years pose a threat to people, hence the need for radiation mitigation strategies. Amifostine, the first FDA approved radioprotector, has shown some toxicities that limit its usage and efficiency. Due to these side effects, scientists have researched for other agents with less toxicity for better radioprotection and possible mitigation of the lethal effects of ionizing radiations after an accidental exposure. Flavonoids have shown promising results for radioprotection and can be administered in higher doses with less toxicity. Studies for mitigation of ionizing radiation-induced toxicities have concentrated on natural antioxidants. Detoxification of free radicals, management of inflammatory responses and attenuation of apoptosis signaling pathways in radiosensitive organs are the main mechanisms for radiation protection and mitigation with flavonoids and natural antioxidants. However, several studies have proposed that a combination in the form of some antioxidants may alleviate radiation toxicities more effectively in comparison to a single form of antioxidants.
Conclusion: In this review, we focus on recent findings about natural radioprotectors and mitigators which are clinically applicable for radiotherapy patients, as well as injured people in possible radiation accidents.
Keywords: Radiation; antioxidant; flavonoids; mitigation; natural antioxidants; radioprotector..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.Clin Transl Oncol. 2019 Mar;21(3):268-279. doi: 10.1007/s12094-018-1934-0. Epub 2018 Aug 22. Clin Transl Oncol. 2019. PMID: 30136132 Review.
-
Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization.Curr Clin Pharmacol. 2019;14(1):41-53. doi: 10.2174/1574884713666181025141559. Curr Clin Pharmacol. 2019. PMID: 30360725 Review.
-
Mechanisms for Radioprotection by Melatonin; Can it be Used as a Radiation Countermeasure?Curr Mol Pharmacol. 2019;12(1):2-11. doi: 10.2174/1874467211666180802164449. Curr Mol Pharmacol. 2019. PMID: 30073934 Review.
-
Radioprotective Effect of Flavonoids on Ionizing Radiation-Induced Brain Damage.Molecules. 2020 Dec 3;25(23):5719. doi: 10.3390/molecules25235719. Molecules. 2020. PMID: 33287417 Free PMC article. Review.
-
Appraisal of mechanisms of radioprotection and therapeutic approaches of radiation countermeasures.Biomed Pharmacother. 2018 Oct;106:610-617. doi: 10.1016/j.biopha.2018.06.150. Epub 2018 Jul 11. Biomed Pharmacother. 2018. PMID: 29990850 Review.
Cited by
-
Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents.Inflammopharmacology. 2022 Feb;30(1):73-89. doi: 10.1007/s10787-021-00894-9. Epub 2021 Nov 23. Inflammopharmacology. 2022. PMID: 34813027 Review.
-
Heparin-binding growth factor (HDGF) drives radioresistance in breast cancer by activating the STAT3 signaling pathway.J Transl Med. 2021 Aug 10;19(1):344. doi: 10.1186/s12967-021-03021-y. J Transl Med. 2021. PMID: 34376200 Free PMC article.
-
Curcumin Enhanced Ionizing Radiation-Induced Immunogenic Cell Death in Glioma Cells through Endoplasmic Reticulum Stress Signaling Pathways.Oxid Med Cell Longev. 2022 Oct 4;2022:5424411. doi: 10.1155/2022/5424411. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36238646 Free PMC article.
-
Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.Clin Transl Oncol. 2019 Mar;21(3):268-279. doi: 10.1007/s12094-018-1934-0. Epub 2018 Aug 22. Clin Transl Oncol. 2019. PMID: 30136132 Review.
-
Protection Against Ionizing Radiation-Induced Normal Tissue Damage by Resveratrol: A Systematic Review.Eurasian J Med. 2020 Oct;52(3):298-303. doi: 10.5152/eurasianjmed.2020.20143. Eurasian J Med. 2020. PMID: 33209085 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical